117 related articles for article (PubMed ID: 32075360)
1. [Clinicopathological characteristics, MSI and K-ras gene mutations of double primary malignancies associated with colorectal cancer].
Li Q; Zhang B; Niu FN; Ye Q; Chen J; Fan XS
Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):301-306. PubMed ID: 32075360
[No Abstract] [Full Text] [Related]
2. Epidemiological and molecular evaluation of BRAF, KRAS, NRAS genes and MSI in the development of colorectal cancer.
Paula Simedan Vila A; Helena Rodrigues G; Leite Marzochi L; Garcia de Oliveira-Cucolo J; Lívia Silva Galbiatti-Dias A; Felipe Maciel Andrade R; de Santi Neto D; Gomes Netinho J; Castiglioni L; Cristina Pavarino É; Maria Goloni-Bertollo E
Gene; 2023 Jun; 870():147395. PubMed ID: 36990254
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
[TBL] [Abstract][Full Text] [Related]
4. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
[TBL] [Abstract][Full Text] [Related]
5. Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.
Yun HR; Yi LJ; Cho YK; Park JH; Cho YB; Yun SH; Kim HC; Chun HK; Lee WY
Int J Colorectal Dis; 2009 Apr; 24(4):369-75. PubMed ID: 18797888
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
7. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
8. Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer.
Niu W; Wang G; Feng J; Li Z; Li C; Shan B
Oncol Lett; 2019 Jan; 17(1):332-338. PubMed ID: 30655771
[TBL] [Abstract][Full Text] [Related]
9. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database.
Uhlig J; Cecchini M; Sheth A; Stein S; Lacy J; Kim HS
J Natl Compr Canc Netw; 2021 Feb; 19(3):307-318. PubMed ID: 33530058
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
13. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.
Won DD; Lee JI; Lee IK; Oh ST; Jung ES; Lee SH
BMC Cancer; 2017 Jun; 17(1):403. PubMed ID: 28583095
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
16. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.
Jeon CH; Lee HI; Shin IH; Park JW
Int J Colorectal Dis; 2008 Jan; 23(1):29-35. PubMed ID: 17704924
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.
Wang C; van Rijnsoever M; Grieu F; Bydder S; Elsaleh H; Joseph D; Harvey J; Iacopetta B
Oncology; 2003; 64(3):259-65. PubMed ID: 12697967
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Relationship Between RAS and RAF Mutations and MSI Status of Colorectal Cancer in Northeastern China.
Li W; Li H; Liu R; Yang X; Gao Y; Niu Y; Geng J; Xue Y; Jin X; You Q; Geng J; Meng H
Cell Physiol Biochem; 2018; 50(4):1496-1509. PubMed ID: 30359964
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.
Levi M; Prayogi G; Sastranagara F; Sudianto E; Widjajahakim G; Gani W; Mahanadi A; Agnes J; Khairunisa BH; Utomo AR
J Gastrointest Cancer; 2018 Jun; 49(2):124-131. PubMed ID: 28044264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
